BAGGIO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.424
AS - Asia 6.295
EU - Europa 2.956
AF - Africa 1.197
SA - Sud America 1.090
OC - Oceania 136
Continente sconosciuto - Info sul continente non disponibili 55
Totale 24.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.879
SG - Singapore 2.116
CN - Cina 1.005
VN - Vietnam 777
HK - Hong Kong 701
BR - Brasile 627
FR - Francia 337
FI - Finlandia 331
DE - Germania 315
UA - Ucraina 281
SE - Svezia 216
IN - India 211
IT - Italia 186
PL - Polonia 180
BD - Bangladesh 124
GB - Regno Unito 119
RU - Federazione Russa 119
TR - Turchia 99
AR - Argentina 96
IQ - Iraq 93
PK - Pakistan 80
PH - Filippine 73
SA - Arabia Saudita 69
EC - Ecuador 67
ZA - Sudafrica 67
MX - Messico 61
ID - Indonesia 59
UZ - Uzbekistan 54
IE - Irlanda 51
VE - Venezuela 51
CO - Colombia 50
JP - Giappone 50
NL - Olanda 49
TH - Thailandia 46
AE - Emirati Arabi Uniti 44
MY - Malesia 44
ES - Italia 43
PE - Perù 42
PY - Paraguay 42
TN - Tunisia 42
CL - Cile 40
KE - Kenya 39
LV - Lettonia 39
AO - Angola 38
ET - Etiopia 38
RS - Serbia 38
JO - Giordania 37
PA - Panama 37
PS - Palestinian Territory 37
BY - Bielorussia 36
CA - Canada 36
CI - Costa d'Avorio 36
DZ - Algeria 36
IL - Israele 36
MA - Marocco 36
AU - Australia 35
EG - Egitto 35
NC - Nuova Caledonia 35
BA - Bosnia-Erzegovina 34
GM - Gambi 34
KZ - Kazakistan 34
LA - Repubblica Popolare Democratica del Laos 34
MN - Mongolia 34
YT - Mayotte 34
KG - Kirghizistan 33
KH - Cambogia 33
MD - Moldavia 33
NP - Nepal 33
RE - Reunion 33
SI - Slovenia 33
AT - Austria 32
IS - Islanda 32
JM - Giamaica 32
BE - Belgio 31
BJ - Benin 31
SO - Somalia 31
ZM - Zambia 31
AM - Armenia 30
BW - Botswana 30
CZ - Repubblica Ceca 30
HU - Ungheria 30
MR - Mauritania 30
TW - Taiwan 30
AZ - Azerbaigian 29
BF - Burkina Faso 29
CH - Svizzera 29
DJ - Gibuti 29
HN - Honduras 29
MK - Macedonia 29
MU - Mauritius 29
SN - Senegal 29
TZ - Tanzania 29
AF - Afghanistan, Repubblica islamica di 28
AL - Albania 28
BZ - Belize 28
CG - Congo 28
GH - Ghana 28
GR - Grecia 28
NZ - Nuova Zelanda 28
RO - Romania 28
Totale 22.847
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.364
Singapore 1.212
San Jose 1.197
Fairfield 1.036
Ashburn 1.007
Jacksonville 914
Ann Arbor 907
Houston 865
Chandler 742
Hong Kong 636
Wilmington 427
Princeton 358
Seattle 354
Cambridge 351
Boardman 262
Ho Chi Minh City 219
Hanoi 168
Lauterbourg 154
Beijing 148
Santa Clara 147
Bytom 136
Helsinki 133
San Diego 100
Los Angeles 97
Des Moines 96
Nanjing 96
Dong Ket 94
Roxbury 89
Medford 72
Guangzhou 71
New York 48
Tashkent 46
São Paulo 42
Baghdad 41
Dublin 39
Hebei 37
Abidjan 34
Noumea 34
Amman 33
Chicago 33
Riga 33
Ulan Bator 33
Luanda 32
Panama City 32
Bishkek 31
Lusaka 31
Nairobi 31
Norwalk 31
Phnom Penh 31
Cotonou 30
Vientiane 30
Dakar 29
Haiphong 29
Nanchang 29
Addis Ababa 28
Nouakchott 28
Baku 27
Minsk 27
Munich 27
Bamako 26
Conakry 26
Kampala 26
Libreville 26
Lima 26
Ouagadougou 26
Reykjavik 26
Tianjin 26
Tokyo 26
Yerevan 26
Accra 25
Dushanbe 25
Kigali 25
Lahore 25
Warsaw 25
Jeddah 24
Jiaxing 24
Kuala Lumpur 24
Vienna 24
Antananarivo 23
Bridgetown 23
Da Nang 23
Dili 23
Djibouti 23
Frankfurt am Main 23
Havana 23
Shenyang 23
Bangkok 22
Harare 22
Managua 22
Montevideo 22
Niamey 22
Quito 22
Auckland 21
Banjul 21
Belgrade 21
Brooklyn 21
Cayenne 21
Guayaquil 21
Mamoudzou 21
Praia 21
Totale 15.373
Salva come PNG Salva come JPEG
Nome #
A critical evaluation of the urinary inhibiting activity in idiopathic calcium oxalate nephrolithiasis. 245
Further insights about the beneficial effects of n-3 fatty acids in the early molecular events of renal fibrosis in vitro. 238
Mesangial cell proliferation in long-term streptozotocin-induced diabetes mellitus in the rat and the renoprotective activity of heparin 232
Arachidonic acid-induced IL-6 expression is mediated by PKCalpha activation in osteoblastic cells 227
Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients 224
Renal impairment and moderate alcohol consumption in the elderly. Results from the Italian Longitudinal Study on Aging (ILSA). 223
An inheritable anomaly of red-cell oxalate transport in "primary" calcium nephrolithiasis correctable with diuretics. 223
Protein diet and hypercalciuria 220
Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells 215
ABNORMAL URATE TRANSPORT IN ERYTHROCYTES OF PATIENTS WITH IDIOPATHIC CALCIUM NEPHROLITHIASIS - A POSSIBLE LINK WITH HYPERURICOSURIA 215
Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid 214
Functional correlation between the Ser/Thr-phosphorylation of band-3 and band-3-mediated transmembrane anion transport in human erythrocytes 212
In vivo activation of renal phospholipase activity by bradykinin in the rat. 212
Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. 208
Renal impairment in chronic cigarette smokers. 206
Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. 205
Tyrosine-protein kinase inhibition in human erythrocytes by polyphosphoinositides (PIP and PIP2) 201
Digitalis and the renin-angiotensin axis in congestive heart failure. 199
Abnormal erythrocyte charge in diabetes mellitus: link with microalbuminuria. 197
Band 3 tyr-phosphorylation in normal and glucose-6-dehydrogenase-defcient huamn erythrocytes 197
ACE inhibitors in renal disease 193
An inheritable anomaly in red-cell oxalate transport in ''primary'' calcium nephrolithiasis correctable with diuretics. 193
Abnormal erythrocyte and renal frusemide-sensitive sodium transport in idiopathic calcium nephrolithiasis. 193
Acquisizione del fenotipo miofibroblastico e transizione epItelio mesenchima in colture primarie di cellule renali umane. 190
Von Willebrand factor abnormalities in IgA nephropathy. 188
Abnormal arachidonic acid content of membrane phospholipids - the unifying hypothesis for the genesis of hypercalciuria and hyperoxaluria in idiopathic calcium nephrolithiasis 187
Arachidonic acid and its metabolites prostaglandin 1 and 2 increase intracellular calcium in cultured human osteoblast-like MG63 cells. 184
Pathogenesis of idiopathic calcium nephrolithiasis: Update 1997 183
DIFFERENT HEPARIN DOSAGES ARE NEEDED TO AMELIORATE THE EVOLUTION OF DIFFERENT EXPERIMENTAL NEPHROPATHIES - DOES THIS MEAN DIFFERENT HEPARIN TARGETS 182
Relationship Between Membrane-protein Phosphorylation and Intracellular Translocation of Casein Kinase In Human Erythrocytes 181
Molecular biology of diabetic glomerulosclerosis 179
DIALYSIS-RELATED AMYLOIDOSIS 177
A comparative kinetic RT/-PCR strategy for the quantitation of mRNAs in microdissected human renal biopsy specimens 177
Abnormal urate transport in erythrocytes of idiopathic calcium nephrolithiasis: a possible link with hyperuricosuria. 171
THERAPY WITH GLYCOSAMINOGLYCANS IN NEPHROLOGY 171
EFFECT OF ALKALINE CITRATE THERAPY ON CLEARANCE OF RESIDUAL RENAL STONE FRAGMENTS AFTER EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY IN STERILE CALCIUM AND INFECTION NEPHROLITHIASIS PATIENTS 170
Experimental peritoneal fibrosis: Favorable effects of glycosaminoglycans (GAGS) 168
Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinoger and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA) 167
Eicosapentaenoic acid modulates CyA-induced proinflammatory cytokine over-expression in osteoblastic cells in vitro 167
Diagnostic and therapeutic approach in patients with urinary calculi 166
Kidney kallikrein and phospholipase activities in Milan spontaneously hypertensive rats. 165
Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis 164
Effect of glucose and heparin on mesangial alpha 1(IV)COLL and MMP-2/TIMP-2 mRNA expression 164
Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes 163
Fatty acids and idiopathic calcium nephrolithiasis 163
ANTIPROTEINURIC EFFECT OF GLYCOSAMINOGLYCANS 162
Renal structure and function in non-insulin dependent diabetic patients with microalbuminura 161
VERY EARLY NUTRITION SUPPLEMENTATION IN BURNED PATIENTS 160
Dietary manipulation of delta-6-desaturase modifies phospholipid arachidonic acid levels and the urinary excretion of calcium and oxalate in the rat: insorgence of calcium lithogenesis 158
Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells 157
EFFECT OF HEPARIN TREATMENT ON GLOMERULAR-ALPHA-1-(IV)-COLLAGEN AND TGF-BETA-1 EXPRESSION AND DEPOSITION IN DIABETIC RATS 157
Patterns of renal injury in NIDDM patients with microalbuminuria 156
Arachidonic acid influences intracellular calcium handling in human osteoblasts 156
EPA and DHA suppress AngII- and arachidonic acid-induced expression of profibrotic genes in human mesangial cells. 155
ERYTHROCYTE URATE SELF EXCHANGE IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 155
Specific modulatory effect of arachidonic acid on bone cytokine mRNA expression 154
Phosphorylation of Band-3 Protein In Nephrolithiasis 153
Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis 153
DIET AND NEPHROLITHIASIS - STUDY IN AN OBESE POPULATION 152
Relation between band 3 red blood cell protein and transmembrane oxalate flux in stone formers. 152
EFFECT OF HEPARIN TREATMENT ON GLOMERULAR COLLAGEN-IV-ALPHA-1 AND TGF-BETA-1 EXPRESSION AND DEPOSITION IN DIABETIC RATS 150
GLYCOSAMINOGLYCAN CONTENT, OXALATE SELF-EXCHANGE AND PROTEIN-PHOSPHORYLATION IN ERYTHROCYTES OF PATIENTS WITH IDIOPATHIC CALCIUM-OXALATE NEPHROLITHIASIS 149
Growth factors and the kidney in diabetes mellitus. 149
Effects of unsaturated free fatty acids on adhesion and on gene expression of extracellular matrix macromolecules in human osteoblast-like cultures 148
Dietary fatty acid supplementation modulates the urinary excretion of calcium and oxalate in the rat. Insight into calcium lithogenesis 148
EFFECTS OF THE ORAL-ADMINISTRATION OF GLYCOSAMINOGLYCANS ON CELLULAR ABNORMALITIES ASSOCIATED WITH IDIOPATHIC CALCIUM-OXALATE NEPHROLITHIASIS 147
Glycosaminoglycans: A new paradigm in the prevention of proteinuria and progression of glomerular disease 147
Vascular endothelial growth factor expression in microdissected glomeruli of type 2 diabetic patients. 146
GLYCOSAMINOGLYCANS (GAGS) IMPROVE PERITONEAL TRANSPORT AND FIBROSIS IN RATS WITH PERITONEAL SCLEROSIS INDUCED BY DIETHYLEXYLPHTALATE (DEHP) 146
Use of glycosaminoglycans to increase efficiency long-term continuous peritoneal dialysis. 146
CORRECTION OF ERYTHROCYTE ABNORMALITIES IN IDIOPATHIC CALCIUM-OXALATE NEPHROLITHIASIS AND REDUCTION OF URINARY OXALATE BY ORAL GLYCOSAMINOGLYCANS 145
Treatment with glycosaminoglycans of renal diseases related problems. 145
Altered Red-blood-cell Membrane-protein Phosphorylation In Idiopathic Calcium-oxalate Nephrolithiasis 145
[Investigation of antibodies adhering to bacteria in children with vesico-ureteral reflux] 144
Quantitative and qualitative changes in VEGF gene expression in glomeruli of patients with type 2 diabetes. 143
Urinary angiotensin-I-converting enzyme activity as a marker of tubulo-interstitial involvement in kidney diseases. 142
Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. 140
ERYTHROCYTE URATE SELF-EXCHANGE IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 140
Genetic approach to the study of cellular ion transport anomalies in idiopathic calcium nephrolithiasis 139
Cardiovascular risk factors, smoking and kidney function 138
ROLE OF GLYCOSAMINOGLYCANS IN DIABETIC NEPHROPATHY 137
Erythrocyte membrane protein phosphorylation in urolithiasis. 137
Relationship between plasma phospholipid polyunsaturated fatty acid composition and bone disease in renal transplantation 136
Isolation and properties of a protein kinase from rat liver microsomes. 133
Ischemic renal disease: impact of cardiovascular risk factors and smoking 132
Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. 132
Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis. 132
Arachidonic acid and its metabolites PGE1 and PGE2 stimulate calcium transport in human osteoblast-like cells. 132
Oral glycosaminoglycans (GAGs) ameliorate peritoneal transport in CAPD patients. 131
Renal function in the elderly: is the decline inevitable? 130
Is hydrochlorothiazide-induced hypocalciuria due to inhibition of prostaglandin E2 synthesis? 130
Glycosaminoglycan therapy prevents TGF-β1 overexpression and pathologic changes in renal tissue of long-term diabetic rats 129
ERYTHROCYTE URATE SELF-EXCHANGE IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 129
Polyunsaturated fatty acids and renal fibrosis:pathophysiologic link and potential clinical implications 127
MOLECULAR PATHOGENESIS OF MEMBRANOUS NEPHROPATHY 127
Chronic treatment with cyclosporin decreases IFN gamma mRNA and increases PRE- PRO ET1 mRNA in rat kidneys 126
Renal structure incaucasian noninsulindependent diabetic patients. 125
ANOMALOUS ARACHIDONIC-ACID METABOLISM IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 124
L’EPARINA RIDUCE L’INFILTRAZIONE MACROFAGICA, LA SINTESI DI TGF* E DI LATENT TGF* BINDING PROTEIN NELLA GLOMERULOSCLEROSI DA PUROMICINA 122
Calcium nephrolithiasis - A systemic disease 121
Totale 16.549
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.130
article - articoli 59.036
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 340
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.068
Totale 131.574
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021364 0 0 0 0 0 0 0 0 0 0 205 159
2021/20221.639 20 255 90 162 112 85 22 168 114 24 193 394
2022/20231.567 364 141 10 167 314 246 1 89 154 6 52 23
2023/2024630 26 82 64 48 34 40 21 123 12 3 91 86
2024/20252.825 4 220 199 108 414 32 100 180 237 101 474 756
2025/202610.550 276 1.043 1.697 1.635 964 550 1.181 1.057 1.185 621 341 0
Totale 24.182